Prosecution Insights
Last updated: October 02, 2026

National University Corporation Chiba University

Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering

6 pending office actions • 5 art units • 6 examiners • 0 of 6 (0%) have an AI response strategy ready • 7 patents granted in the last 365 days

Analysis

National University Corporation Chiba University holds a patent portfolio in the Medical Devices & Mechanical Engineering technology area. The portfolio currently has 6 pending office actions. This indicates an active phase of prosecution for the university's medical and mechanical innovations across several pending applications.

The university's applications are being examined by 6 distinct examiners across 5 distinct art units. This distribution is notable because nearly every pending action is being handled in a different art unit. Such a high ratio of 5 distinct art units for only 6 pending office actions suggests that the university's research is multidisciplinary and covers many different specialized categories within medical devices and engineering.

RABAGLIA, BRIDGET ELIZABETH is the busiest examiner for this portfolio, with 1 busiest examiner pending office action. Because there are 6 distinct examiners for 6 pending office actions, the workload is evenly spread across the patent office. The university must manage 6 unique examiner relationships, each likely operating within the distinct frameworks of the 5 different art units involved in the process.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

6
Total Pending OAs
3
Non-Final OAs
3
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

3
Overdue
0
Due this week
0
Due this month
0
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (3)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

5
Hard (83%)
1
Medium (17%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 only1 (17%)
§103 only1 (17%)
Multi-statute (no §101)4 (67%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

2
Life Sciences
33% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
3
Mechanical / Eng
50% of docket
1
Business / Other
17% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

60 h
Manual time on pending OAs
12 h
Time saved (low, 20%)
21 h
Time saved (mid, 35%)
0.5 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
RABAGLIA, BRIDGET ELIZABETH 1 68.5% +15.9%
BUGG, PAIGE KATHLEEN 1 58.6% +58.7%
CASLER, BRIAN L 1 78.8% +22.2%
TRAN, ERIC 1 70.8% +23.3%
GIERE, REBECCA M 1 73.7% +32.3%
HOUGH, JESSANDRA F 1 45.6% +35.8%

Hard Cases (5)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 5 ordered by deadline are shown.

App #TitleExaminerDue in
16484523 BED MONITORING SYSTEM HOUGH, JESSANDRA F 72d overdue
18524823 IN-VIVO VISUALIZATION DEVICE CASLER, BRIAN L 18d overdue
18855971 SUTURE FOR USE IN FLEXIBLE ENDOSCOPIC SURGERIES RABAGLIA, BRIDGET ELIZABETH —
18690884 MASSAGE APPARATUS BUGG, PAIGE KATHLEEN —
18043999 ALLERGIC DISEASE DETERMINATION METHOD AND DETERMINATION SYSTEM GIERE, REBECCA M —

Interview Candidates (6)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 6 ordered by deadline are shown.

App #TitleExaminerDue in
16484523 BED MONITORING SYSTEM HOUGH, JESSANDRA F 72d overdue
18508831 R-KETAMINE AND DERIVATIVE THEREOF AS PROPHYLACTIC OR THERAPEUTIC AGENT FOR NEURODEGENERATION DISEASE OR RECOGNITION FUNCTIONAL DISORDER TRAN, ERIC 35d overdue
18524823 IN-VIVO VISUALIZATION DEVICE CASLER, BRIAN L 18d overdue
18855971 SUTURE FOR USE IN FLEXIBLE ENDOSCOPIC SURGERIES RABAGLIA, BRIDGET ELIZABETH —
18690884 MASSAGE APPARATUS BUGG, PAIGE KATHLEEN —
18043999 ALLERGIC DISEASE DETERMINATION METHOD AND DETERMINATION SYSTEM GIERE, REBECCA M —

Top Art Units

Art UnitApps
3771 1
3791 1
1629 1
1677 1
3796 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18855971 SUTURE FOR USE IN FLEXIBLE ENDOSCOPIC SURGERIES RABAGLIA, BRIDGET ELIZABETH 3771 §102§103 Non-Final OA — Pending Oct 10, 2024
18690884 MASSAGE APPARATUS BUGG, PAIGE KATHLEEN — §103§112 Non-Final OA — Pending Mar 11, 2024
18524823 IN-VIVO VISUALIZATION DEVICE CASLER, BRIAN L 3791 §102§103 Final Rejection 18d overdue Pending Nov 30, 2023
18508831 R-KETAMINE AND DERIVATIVE THEREOF AS PROPHYLACTIC OR THERAPEUTIC AGENT FOR NEURODEGENERATION DISEASE OR RECOGNITION FUNCTIONAL DISORDER TRAN, ERIC 1629 §103 Final Rejection 35d overdue Pending Nov 14, 2023
18043999 ALLERGIC DISEASE DETERMINATION METHOD AND DETERMINATION SYSTEM GIERE, REBECCA M 1677 §103§112 Final Rejection — Pending Mar 03, 2023
16484523 BED MONITORING SYSTEM HOUGH, JESSANDRA F 3796 §101 Non-Final OA 72d overdue Pending Dec 19, 2019

Managing National University Corporation Chiba University's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month